83 research outputs found

    Additional file 1: of HTT2 promotes plant thermotolerance in Brassica rapa

    No full text
    Table S1. Primers for expression analysis of qRT-PCR, cDNA cloning of HTT2, and identification of HPT gene in transgenic plants. (DOCX 20 kb

    DataSheet1_Co-crystalization reveals the interaction between AtYchF1 and ppGpp.docx

    No full text
    AtYchF1 is an unconventional G-protein in Arabidopsis thaliana that exhibits relaxed nucleotide-binding specificity. The bindings between AtYchF1 and biomolecules including GTP, ATP, and 26S rRNA have been reported. In this study, we demonstrated the binding of AtYchF1 to ppGpp in addition to the above molecules. AtYchF1 is a cytosolic protein previously reported as a negative regulator of both biotic and abiotic stresses while the accumulation of ppGpp in the cytoplasm induces retarded plant growth and development. By co-crystallization, in vitro pull-down experiments, and hydrolytic biochemical assays, we demonstrated the binding and hydrolysis of ppGpp by AtYchF1. ppGpp inhibits the binding of AtYchF1 to ATP, GTP, and 26S rRNA. The ppGpp hydrolyzing activity of AtYchF1 failed to be activated by AtGAP1. The AtYchF1-ppGpp co-crystal structure suggests that ppGpp might prevent His136 from executing nucleotide hydrolysis. In addition, upon the binding of ppGpp, the conformation between the TGS and helical domains of AtYchF1 changes. Such structural changes probably influence the binding between AtYchF1 and other molecules such as 26S rRNA. Since YchF proteins are conserved among different kingdoms of life, the findings advance the knowledge on the role of AtYchF1 in regulating nucleotide signaling as well as hint at the possible involvement of YchF proteins in regulating ppGpp level in other species.</p

    ROC analysis showing agreement between global motion test and pattern glare test.

    No full text
    <p>ROC curves after the first session (A), the 5<sup>th</sup> session (B), and after a break for a month (C). The AUC was plotted as a function of numbers of sessions (D). Orange, sessions in the first visit; purple, after a 1-month break.</p

    Stimulus and experimental procedure.

    No full text
    <p>(A) Kinematogram with different levels of coherence with dots moving in the same direction presented as filled one. (B) Experimental procedure. (C) An example of results obtained from a staircase with a 3-down-1-up paradigm.</p

    The thresholds to detect global motion reduced after practice.

    No full text
    <p>Top panels: Line plot illustrating the changes in threshold to detect global motion with training sessions in normal subjects (A) and those with PRVS (B). Gray lines represent individual subjects’ data and colored symbols represent mean values after each session. Bottom panel: probability density plot for the threshold to detect global motion after the 1<sup>st</sup> session (C) and the 5<sup>th</sup> session (D). Blue: normal subjects; red: subjects with PRVS.</p

    The expression of HMGB1 and TLR4 increases in the ILA model.

    No full text
    <p>(A and B): Real-time PCR and Western blot show the increased expression of HMGB1 in the inflamed corneas after the ILA surgery. (C and D): Real-time PCR and Western blot show the increased expression of TLR4 in the inflamed corneas after the ILA surgery was performed. *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001 (compared with normal corneas).</p

    Polysaccharide Hydrogel Combined with Mesenchymal Stem Cells Promotes the Healing of Corneal Alkali Burn in Rats

    No full text
    <div><p>Corneal chemical burns are common ophthalmic injuries that may result in permanent visual impairment. Although significant advances have been achieved on the treatment of such cases, the structural and functional restoration of a chemical burn-injured cornea remains challenging. The applications of polysaccharide hydrogel and subconjunctival injection of mesenchymal stem cells (MSCs) have been reported to promote the healing of corneal wounds. In this study, polysaccharide was extracted from Hardy Orchid and mesenchymal stem cells (MSCs) were derived from Sprague-Dawley rats. Supplementation of the polysaccharide significantly enhanced the migration rate of primarily cultured rat corneal epithelial cells. We examined the therapeutic effects of polysaccharide in conjunction with MSCs application on the healing of corneal alkali burns in rats. Compared with either treatment alone, the combination strategy resulted in significantly better recovery of corneal epithelium and reduction in inflammation, neovascularization and opacity of healed cornea. Polysaccharide and MSCs acted additively to increase the expression of anti-inflammatory cytokine (TGF-β), antiangiogenic cytokine (TSP-1) and decrease those promoting inflammation (TNF-α), chemotaxis (MIP-1α and MCP-1) and angiogenesis (VEGF and MMP-2). This study provided evidence that Hardy Orchid derived polysaccharide and MSCs are safe and effective treatments for corneal alkali burns and that their benefits are additive when used in combination. We concluded that combination therapy with polysaccharide and MSCs is a promising clinical treatment for corneal alkali burns and may be applicable for other types of corneal disorder.</p></div

    High Mobility Group Box-1 Promotes Inflammation-Induced Lymphangiogenesis via Toll-Like Receptor 4-Dependent Signalling Pathway

    No full text
    <div><p>Lymphangiogenesis in inflammation has received considerable attention in recent years. Administration of modulating lymphangiogenesis provides more possibilities of treating inflammation-associated diseases. However, the main mediators and factors governing inflammation-induced lymphangiogenesis (ILA) are yet to be defined. Here, we explored the role of HMGB1-TLR4 signalling pathway in modulating inflammation-induced lymphangiogenesis and its underlying mechanisms using an ILA mouse model and 2 cell lines. Our results show that HMGB1 promoted VEGF-C-induced HDLECs proliferation in a dose-dependent manner and TLR4 mediates HMGB1-induced LECs proliferation and tube formation <i>in vitro</i>. And <i>in vivo</i>, rHMGB1 treatment significantly promoted ILA, and the promoting effects was inhibited notably when HMGB1-TLR4 was blocked. HMGB1-associated ILA is primarily dependent on TLR4 but not on TLR2. In mechanisms, the recruitment and activation of CD11b+ cells are important cellular mechanisms in HMGB1-TLR4 associated ILA, and multiple key pro-lymphangiogenesis molecules mediates HMGB1-TLR4 associated ILA, including VEGF-C/VEGFR3, inflammatory factors IL-1β and TNF-α, MMP-2 and MMP-9 and NF-κB p65. In conclusion, HMGB1-associated ILA is primarily dependent on TLR4, and CD11b+ cells and multiple molecular mechanisms mediate HMGB1-TLR4 associated ILA. Furthermore, the ILA can be effectively modulated by HMGB1-TLR4 signalling. Consequently, administration of modulating ILA through HMGB1-TLR4 pathway may provide us more possibilities of treating inflammation and lymphangiogenesis associated diseases.</p></div
    corecore